AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Einhorn's Greenlight Capital Takes New Positions in FLR and VSCO, Exits VTRS.
ByAinvest
Saturday, Aug 16, 2025 2:39 am ET1min read
David Einhorn's Greenlight Capital has added Fluor and Victoria's Secret to its portfolio, while exiting VTRS. The hedge fund holds 760.6K shares of Fluor and 168.3K shares of Victoria's Secret. The exact trades are not specified in the article.
David Einhorn's Greenlight Capital has made notable adjustments to its portfolio during the second quarter of 2025. The hedge fund has added significant stakes in Fluor (NYSE: FLR) and Victoria's Secret (NYSE: VSCO), while simultaneously exiting its position in Viatris (NASDAQ: VTRS) [1]. According to the latest 13F filing released on Thursday, Greenlight Capital now holds 760.6K shares of Fluor and 168.3K shares of Victoria's Secret.Greenlight Capital also bolstered its positions in PENN Entertainment (PENN) and Graphic Packaging Holding Company (GPK). The firm increased its stake in PENN from ~6.3M shares in Q1 to ~7.5M shares in Q2 and in GPK from ~1.1M shares to ~4.7M shares during the same period. Additionally, the hedge fund reduced its holding in Peloton Interactive (PTON) from ~5.0M shares to ~180K shares [1].
The move to add Fluor and Victoria's Secret to its portfolio could be indicative of Greenlight Capital's confidence in the future prospects of these companies. Fluor, a global engineering and construction firm, has been involved in several high-profile projects, including the construction of the LNG terminal in Santos, Brazil, which resulted in a legal dispute with Fluor. Victoria's Secret, known for its luxury lingerie and accessories, has been expanding its e-commerce presence and has recently won the FDA nod for a generic iron sucrose injection targeting Daiichi’s Venofer [1].
Conversely, the exit from Viatris could be due to various reasons, including changes in the company's strategic direction or performance. Viatris, a pharmaceutical company, has been focusing on generic drugs and has been involved in legal disputes related to its operations.
Overall, these moves by Greenlight Capital suggest a strategic realignment of its portfolio, with a focus on companies with strong growth prospects and potential for long-term value creation.
References:
[1] https://seekingalpha.com/news/4485554-david-einhorns-greenlight-capital-adds-flr-vsco-exits-vtrs-among-other-trades
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet